Massachusetts

  • April 29, 2026

    Judge Blocks ICE From Making Arrest At Green Card Interview

    A Massachusetts federal judge issued an emergency order protecting the spouse of an American citizen from being detained during her green card interview Wednesday after she filed a lawsuit claiming immigration enforcers have turned the mandatory interviews into a trap for people who are on the path to legal residency.

  • April 29, 2026

    Mass. AG, Insurer Settle Deceptive Marketing Claims For $5M

    A Texas-headquartered health insurance agency will pay $5 million to settle allegations that it engaged in deceptive and unfair marketing to sell plans and other types of health programs to thousands of Massachusetts consumers, the state's attorney general announced on Wednesday.

  • April 29, 2026

    Lender Seeks Receivership Over $8M Pot Shop Default

    A lender says a pot dispensary across from Fenway Park owes it $8 million and should be placed into receivership, the latest in a series of lawsuits against one of Massachusetts' first social equity cannabis license recipients.

  • April 29, 2026

    Mass. Judge Clears Way For Trader Joe's 401(k) Plan Trial

    A Massachusetts federal judge has denied summary judgment to Trader Joe's ahead of a Monday trial on claims that it mismanaged its employee retirement plan. 

  • April 29, 2026

    Bausch Balks At Suspected Tweak In Price-Fixing Deals

    A stipulation between state attorneys general and private plaintiffs suing generic-drug makers for alleged price-fixing seems to reflect a change in the states' earlier deal to release claims against Bausch entities, the companies said in asking a Connecticut federal judge to maintain the status quo.

  • April 29, 2026

    Ropes & Gray Guides Italy's Chiesi On $1.9B US Biotech Deal

    Chiesi Group said Wednesday it will acquire KalVista Pharmaceuticals in a deal valued at about $1.9 billion, expanding the Italian biopharmaceutical company's rare disease portfolio with a newly approved treatment for a rare hereditary swelling disorder. 

  • April 28, 2026

    2nd Circ. Splits With 5th, 8th On Migrant Bond Detention

    A unanimous Second Circuit panel on Tuesday rejected the Trump administration's argument that noncitizens who entered the U.S. unlawfully, regardless of their length of stay, aren't eligible for bond, diverging from the Fifth and Eighth circuits.

  • April 28, 2026

    DOD Scoffs At Clement & Murphy, Jenner & Block Fee Ask

    The U.S. Department of Defense took aim at Clement & Murphy PLLC and Jenner & Block LLP's request for "inflated" attorney fees in their successful challenge to a DOD cap on indirect research costs, urging a federal judge to reject the request or, in the alternative, award about a quarter of the firms' $530,000 ask.

  • April 28, 2026

    Boston To Pay $850K In Settlement With 2020 Protesters

    Attorneys representing four protesters said Tuesday that the city of Boston has agreed to pay $850,000 to settle claims that police officers used excessive force on demonstrators protesting the killing of George Floyd in 2020.

  • April 28, 2026

    Federal Inmates Can Earn Credits In State Lockup, 1st Circ. Says

    Federal prisoners may earn First Step Act time credit toward shortening their sentences during state custody before arriving at a federal prison, the First Circuit ruled, deeming a contrary federal policy invalid.

  • April 28, 2026

    BU Flouted Student's Brain Injury Accommodations, Suit Says

    A former student and instructor at Boston University says she was forced out of her doctoral program after a faculty adviser and an administrator interfered with previously approved disability accommodations following a traumatic brain injury.

  • April 27, 2026

    Meta Seeks A Rally As Instagram Addiction Suit Losses Mount

    After a run of litigation losses, Meta Platforms Inc. will have to rethink its strategy in and out of court in an effort to beat back suits from coast to coast claiming that it is illegally hooking kids on Instagram, experts said, with everything from aggressive litigation to a global settlement on the table.

  • April 27, 2026

    Battery Co. Hit With Investor Action Over 'Phantom Deals'

    Investors in a company that develops artificial intelligence-enhanced rechargeable batteries filed suit on Monday, claiming the company made misleading statements about its partnerships with other companies and its growth prospects, seeking damages for falling stock prices after the truth came to light.

  • April 27, 2026

    New Wave Of Migrant Parole Cancellations To Go On, For Now

    A Massachusetts federal judge on Monday declined to stop the Trump administration from issuing new notices ending parole for noncitizens who used a government app to enter the U.S., despite claims that the government is circumventing an earlier court order that reinstated their parole.

  • April 27, 2026

    Moderna Hit With Suit Over CureVac COVID Patents

    BioNTech subsidiary CureVac has launched a new patent infringement suit against Moderna, claiming its COVID-19 vaccine infringed a handful of patents, saying the Massachusetts-based company "exploited" its messenger RNA technology.

  • April 27, 2026

    Mass. Justices Back Records Petition, Reject Pay Proposal

    Massachusetts' highest court said on Monday it saw no immediate reason to block a ballot measure that would expand the state's public records law to cover both the Legislature and governor, yet it found a second initiative tying lawmaker stipends to performance improperly steps on state Senate rules.

  • April 27, 2026

    AGs Say Live Nation Fix Can't Wait On DOJ Deal Approval

    Live Nation Entertainment Inc. sparred with state attorneys general expected to seek a forced Ticketmaster sale after winning a New York federal jury antitrust verdict, with the company seeking to delay the breakup fight until after the judge reviews a separate U.S. Department of Justice settlement, and the enforcers preferring parallel proceedings.

  • April 27, 2026

    4 Firms Build Astorg's $1.1B Microbiology Biz Buy

    Life sciences company Thermo Fisher Scientific Inc. on Monday announced plans to sell its microbiology business to European private equity firm Astorg in an over $1.1 billion deal steered by four law firms.

  • April 27, 2026

    McCarter & English Plans New Waterfront Home In Boston

    New Jersey-based McCarter & English LLP has chosen a new home for its Boston office, opting for a location in the middle of the city's downtown waterfront district, the firm has announced.

  • April 27, 2026

    Ropes & Gray, Cooley Lead Lilly's $2.3B Cancer Drug Buy

    Eli Lilly and Co. said Monday it will acquire privately held Ajax Therapeutics in a deal worth up to $2.3 billion, as the drugmaker looks to expand its pipeline of treatments for blood cancers.

  • April 27, 2026

    Star Sprinter Says Puma Shoes Caused Career-Ending Injuries

    Two-time world champion sprinter Abby Steiner, who in 2022 signed an endorsement deal with Puma, has blamed the brand's shoes for injuries that ended her career and brought a $1.2 million product liability lawsuit in Massachusetts state court.

  • April 27, 2026

    Mass. Fines Fidelity $1.25M Over 'Image ID' Data Breach

    A Fidelity unit has agreed to pay a $1.25 million fine to end Massachusetts' claims that a failure to enforce cybersecurity protocols led to a data breach affecting 77,000 brokerage customers, according to a consent order filed on Monday with the Office of the Secretary of the Commonwealth.

  • April 24, 2026

    10 States Say EPA Must Enforce Clean Air Act Soot Rule

    A coalition of 10 states and three local governments sued the U.S. Environmental Protection Agency on Friday, claiming the agency has failed to implement a Clean Air Act rule regulating soot and is thereby endangering public health across the country.

  • April 24, 2026

    Mass. Judge Tells Feds Not To Deport Harvard Researcher

    A Massachusetts federal judge on Friday ordered the government to act on a Harvard researcher's request to renew her expiring J-1 visa and to not take any steps toward deporting her while a criminal smuggling case is pending.

  • April 24, 2026

    Judge Shields More Colleges From Admissions Data Survey

    A Boston federal judge on Friday blocked enforcement of the federal government's demand for seven years' worth of college admissions data from dozens of universities, following an earlier ruling enjoining the U.S. Department of Education survey for the public colleges of 17 states.

Expert Analysis

  • Series

    Law School's Missed Lessons: Skillful Persuasion

    Author Photo

    In many ways, law school teaches us how to argue, but when the ultimate goal is to get your client what they want, being persuasive through preparation and humility is the more likely key to success, says Michael Friedland at Friedland Cianfrani.

  • Litigation Inspiration: How To Respond After A Loss

    Author Photo

    Every litigator loses a case now and then, and the sting of that loss can become a medicine that strengthens or a poison that corrodes, depending on how the attorney responds, says Bennett Rawicki at Hilgers Graben.

  • While On Firmer Ground, Uncertainty Remains For SEC's ALJs

    Author Photo

    The U.S. District Court for the District of Columbia's recent opinion in Lemelson v. U.S. Securities and Exchange Commission affirmed the legitimacy of the SEC's administrative proceedings, but pointedly left unanswered the constitutional merits of tenure protection enjoyed by SEC administrative law judges — potentially the subject of future U.S. Supreme Court review, says Dean Conway at Carlton Fields.

  • FDA's Hasty Policymaking Approach Faces APA Challenges

    Author Photo

    Though the U.S. Food and Drug Administration has abandoned its usual notice-and-comment process for implementing new regulatory initiatives, two recent district court decisions make clear that these programs are still susceptible to Administrative Procedure Act challenges, says Rachel Turow at Skadden.

  • The Metamorphosis Of The Major Questions Doctrine

    Author Photo

    The so-called major questions doctrine arose as a counterweight to Chevron deference over the past few decades, but invocations of the doctrine have persisted in the year since Chevron was overturned, suggesting it still has a role to play in reining in agency overreach, say attorneys at Crowell & Moring.

  • Series

    Playing Mah-Jongg Makes Me A Better Mediator

    Author Photo

    Mah-jongg rewards patience, pattern recognition, adaptability and keen observation, all skills that are invaluable to my role as a mediator, and to all mediating parties, says Marina Corodemus.

  • Calif. Air Waivers Fight Fuels Automakers', States' Uncertainty

    Author Photo

    The unprecedented attempt by Congress and the Trump administration to kill the Clean Air Act waivers supporting California's vehicle emissions standards will eventually end up in the U.S. Supreme Court — but meanwhile, vehicle manufacturers, and states following California's standards, are left in limbo, says John Watson at Spencer Fane.

  • Series

    Law School's Missed Lessons: Navigating Client Trauma

    Author Photo

    Law schools don't train students to handle repeated exposure to clients' traumatic experiences, but for litigators practicing in areas like civil rights and personal injury, success depends on the ability to view cases clinically and to recognize when you may need to seek help, says Katie Bennett at Robins Kaplan.

  • Opinion

    4 Former Justices Would Likely Frown On Litigation Funding

    Author Photo

    As courts increasingly confront cases involving hidden litigation finance contracts, the jurisprudence of four former U.S. Supreme Court justices establishes a constitutional framework that risks erosion by undisclosed financial interests, says Roland Eisenhuth at the American Property Casualty Insurance Association.

  • Quantifying Trading-Based Damages Using Price Impact

    Author Photo

    The U.S. Securities and Exchange Commission will likely increasingly rely on price impact analyses to demonstrate pecuniary harm from trading-related misconduct, meaning measuring price impact will be helpful in challenging SEC disgorgement, determining appropriate remedies, and assessing loss causation and damages in private litigation, says Vyacheslav Fos at Boston College and Erin Smith at Compass Lexecon.

  • State Law Challenges In Enforcing Arbitration Clauses

    Author Photo

    In recent cases, state courts in Pennsylvania, Massachusetts and New Jersey have considered or endorsed heightened standards for arbitration agreements, which can mean the difference between a bilateral arbitration and a full-blown class action in court, says Fabien Thayamballi at Shapiro Arato.

  • How Attys Can Use AI To Surface Narratives In E-Discovery

    Author Photo

    E-discovery has reached a turning point where document review is no longer just about procedural tasks like identifying relevance and redacting privilege — rather, generative artificial intelligence tools now allow attorneys to draw connections, extract meaning and tell a coherent story, says Rose Jones at Hilgers Graben.

  • Series

    Playing The Violin Makes Me A Better Lawyer

    Author Photo

    Playing violin in a string quartet reminds me that flexibility, ambition, strong listening skills, thoughtful leadership and intentional collaboration are all keys to a successful legal practice, says Julie Park at MoFo.

  • Series

    Law School's Missed Lessons: Practicing Self-Care

    Author Photo

    Law schools don’t teach the mental, physical and emotional health maintenance tools necessary to deal with the profession's many demands, but practicing self-care is an important key to success that can help to improve focus, manage stress and reduce burnout, says Rachel Leonard​​​​​​​ at MG+M.

  • Birthright Opinions Reveal Views On Rule 23(b)(2) Relief

    Author Photo

    The justices' multiple opinions in the U.S. Supreme Court’s June 27 decision in the birthright citizenship case, Trump v. CASA, shed light on whether Rule 23(b)(2) could fill the void created by the court's decision to restrict nationwide injunctions, says Benjamin Johns at Shub Johns.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Massachusetts archive.